(Q31038817)

28 June 2017

title

Role of iron in neurodegenerative diseases (English)

1 reference

28 June 2017

1 reference

2

Heinz Reichmann

1 reference

28 June 2017

Kai Li

1

1 reference

28 June 2017

publication date

21 January 2016

1 reference

Journal of Neural Transmission

28 June 2017

published in

1 reference

28 June 2017

volume

123

1 reference

28 June 2017

issue

4

1 reference

28 June 2017

page(s)

389-399

1 reference

https://scigraph.springernature.com/pub.10.1007/s00702-016-1508-7

28 June 2017

exact match

0 references

cites work

Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Quantitative 7T phase imaging in premanifest Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Neuroprotective and neurorestorative activities of a novel iron chelator-brain selective monoamine oxidase-A/monoamine oxidase-B inhibitor in animal models of Parkinson's disease and aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Increased basal ganglia iron levels in Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Iron overload accelerates neuronal amyloid-β production and cognitive impairment in transgenic mice model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Substantia nigra echomorphology in the healthy very old: Correlation with motor slowing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Iron-sulfur clusters: nature's modular, multipurpose structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Hyperechogenicity of the substantia nigra: pitfalls in assessment and specificity for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7 T MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Brain iron deposition fingerprints in Parkinson's disease and progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Forecasting the global burden of Alzheimer’s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Frataxin acts as an iron chaperone protein to modulate mitochondrial aconitase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Labile iron in cells and body fluids: physiology, pathology, and pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Changes in iron-regulatory gene expression occur in human cell culture models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

The role of iron as a mediator of oxidative stress in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Iron accumulates in Huntington's disease neurons: protection by deferoxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Ceruloplasmin levels in the human superior temporal gyrus in aging and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Isoforms of ferritin have a specific cellular distribution in the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer's diseased brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Intramuscular desferrioxamine in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Genetic and biochemical markers in patients with Alzheimer's disease support a concerted systemic iron homeostasis dysregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Brain iron metabolism and its perturbation in neurological diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Alpha-synuclein is a cellular ferrireductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Targeting chelatable iron as a therapeutic modality in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Decreased ferritin levels in brain in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Ferrous iron formation following the co-aggregation of ferric iron and the Alzheimer's disease peptide β-amyloid (1-42).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Huntingtin inclusion bodies are iron-dependent centers of oxidative events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Genetics and iron in the systems biology of Parkinson's disease and some related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Ferritin up-regulation and transient ROS production in cultured brain astrocytes after loading with iron oxide nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Iron-dependent functions of mitochondria--relation to neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

New developments in depression, anxiety, compulsiveness, and hallucinations in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Magnesium inhibits spontaneous and iron-induced aggregation of alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Ceruloplasmin activity and iron chelation treatment of patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Clioquinol decreases amyloid-beta burden and reduces working memory impairment in a transgenic mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Decrease in APP and CP mRNA expression supports impairment of iron export in Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Deferoxamine inhibits iron induced hippocampal tau phosphorylation in the Alzheimer transgenic mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Olfactory loss may be a first sign of idiopathic Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Expression of ferritin protein and subunit mRNAs in normal and iron deficient rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

The biochemistry of heme biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Huntingtin: an iron-regulated protein essential for normal nuclear and perinuclear organelles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Iron accumulation, iron-mediated toxicity and altered levels of ferritin and transferrin receptor in cultured astrocytes during incubation with ferric ammonium citrate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Up-regulation of divalent metal transporter 1 in 6-hydroxydopamine intoxication is IRE/IRP dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

The Haber-Weiss reaction and mechanisms of toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Superoxide accelerates DNA damage by elevating free-iron levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Regulating the fate of mRNA: the control of cellular iron metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Friedreich's ataxia causes redistribution of iron, copper, and zinc in the dentate nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Friedreich ataxia: metal dysmetabolism in dorsal root ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Novel molecular targets of the neuroprotective/neurorescue multimodal iron chelating drug M30 in the mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Seven-Tesla magnetic resonance images of the substantia nigra in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Cellular iron uptake, trafficking and metabolism: Key molecules and mechanisms and their roles in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

7 Tesla magnetic resonance imaging: a closer look at substantia nigra anatomy in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Each member of the poly-r(C)-binding protein 1 (PCBP) family exhibits iron chaperone activity toward ferritin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Functional roles of transferrin in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Transcranial sonography of the substantia nigra and its correlation with DAT-SPECT in the diagnosis of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Mechanisms of iron-sulfur protein maturation in mitochondria, cytosol and nucleus of eukaryotes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Susceptibility-weighted imaging changes suggesting brain iron accumulation in Huntington's disease: an epiphenomenon which causes diagnostic difficulty

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Alzheimer's disease: clinical trials and drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Dysregulation of cellular iron metabolism in Friedreich ataxia: from primary iron-sulfur cluster deficit to mitochondrial iron accumulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Mitochondrial iron homeostasis and its dysfunctions in neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Assessment of brain iron and neuronal integrity in patients with Parkinson's disease using novel MRI contrasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Neuroimaging of rapid eye movement sleep behavior disorder: transcranial ultrasound, single-photon emission computed tomography, and positron emission tomography scan data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Immunohistochemical localization of intraneuronal transferrin receptor immunoreactivity in the adult mouse central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Ferroportin in the postnatal rat brain: implications for axonal transport and neuronal export of iron.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Brain capillary endothelial cells mediate iron transport into the brain by segregating iron from transferrin without the involvement of divalent metal transporter 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Iron dysregulation in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Crosslinking of alpha-synuclein by advanced glycation endproducts--an early pathophysiological step in Lewy body formation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Discovery of genes essential for heme biosynthesis through large-scale gene expression analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Deferiprone in Friedreich ataxia: a 6-month randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Electron transport chain defects in Alzheimer's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Iron uptake in quiescent and inflammation-activated astrocytes: a potentially neuroprotective control of iron burden

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

High nigral iron deposition in LRRK2 and Parkin mutation carriers using R2* relaxometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

The systemic iron-regulatory proteins hepcidin and ferroportin are reduced in the brain in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Iron homeostasis in astrocytes and microglia is differentially regulated by TNF-α and TGF-β1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Clinical MRI for iron detection in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

The role of iron regulatory proteins in mammalian iron homeostasis and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

The role of iron in gray matter degeneration in Huntington's disease: a magnetic resonance imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Oxidative stress induces degradation of mitochondrial DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

A potential pathogenetic role of iron in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Furin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Ferroportin 1 but not hephaestin contributes to iron accumulation in a cell model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Tim-2 is the receptor for H-ferritin on oligodendrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Transcranial color-coded sonography helps differentiation between idiopathic Parkinson's disease and vascular parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

The interplay between iron accumulation, mitochondrial dysfunction, and inflammation during the execution step of neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

7T T₂*-weighted magnetic resonance imaging reveals cortical phase differences between early- and late-onset Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Characterization and modulation of the transferrin receptor on brain capillary endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

β-Amyloid peptide increases levels of iron content and oxidative stress in human cell and Caenorhabditis elegans models of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

The role of iron in brain ageing and neurodegenerative disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Longitudinal midbrain changes in early Parkinson's disease: iron content estimated from R2*/MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Activated iron-containing microglia in the human hippocampus identified by magnetic resonance imaging in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Electron transfer by domain movement in cytochrome bc1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Divalent metal transporter 1 is involved in amyloid precursor protein processing and Abeta generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Neuromelanin of the human substantia nigra: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

In Situ Oxidative Catalysis by Neurofibrillary Tangles and Senile Plaques in Alzheimer’s Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

Amyloid-β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

An iron–dopamine index predicts risk of parkinsonian neurodegeneration in the substantia nigra pars compacta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-016-1508-7

The significance of the mutated divalent metal transporter (DMT1) on iron transport into the Belgrade rat brain.

21 January 2018

1 reference

12 December 2020

Divalent metal transporter 1 (DMT1) in the brain: implications for a role in iron transport at the blood-brain barrier, and neuronal and glial pathology

1 reference

12 December 2020

The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity

1 reference

12 December 2020

Midbrain iron content in early Parkinson disease: a potential biomarker of disease status

1 reference

12 December 2020

Fenton chemistry: an introduction.

1 reference

12 December 2020

α-Synuclein Over-Expression Induces Increased Iron Accumulation and Redistribution in Iron-Exposed Neurons.

1 reference

12 December 2020

Clinically available iron chelators induce neuroprotection in the 6-OHDA model of Parkinson's disease after peripheral administration

1 reference

12 December 2020

The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease

1 reference

12 December 2020

The iron regulatory capability of the major protein participants in prevalent neurodegenerative disorders

1 reference

12 December 2020

Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease

1 reference

12 December 2020

Expression of the neuronal transferrin receptor is age dependent and susceptible to iron deficiency.

1 reference

12 December 2020

Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography

1 reference

12 December 2020

Protein oxidation and aging

1 reference

12 December 2020

Iron (III) induces aggregation of hyperphosphorylated tau and its reduction to iron (II) reverses the aggregation: implications in the formation of neurofibrillary tangles of Alzheimer's disease.

1 reference

12 December 2020

Synthesis of the Proteins of Complex III of the Mitochondrial Respiratory Chain in Heme‐Deficient Cells

1 reference

12 December 2020

Multi-target iron-chelators improve memory loss in a rat model of sporadic Alzheimer's disease

1 reference

12 December 2020

Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains

1 reference

12 December 2020

Region-specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping.

1 reference

12 December 2020

Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress.

1 reference

12 December 2020

Iron levels modulate alpha-secretase cleavage of amyloid precursor protein

1 reference

12 December 2020

The dorsal root ganglion in Friedreich's ataxia

1 reference

12 December 2020

10.1007/S00702-016-1508-7

Identifiers

DOI

1 reference

Dimensions Publication ID

28 June 2017

1018422661

0 references

Fatcat ID

release_ppj3vsmwlzgadavfueal6kopvi

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ppj3vsmwlzgadavfueal6kopvi

24 November 2022

mapped directly with Wikidata item

1 reference